Tennis-World No 1 Sinner cleared of wrongdoing after failed drug tests, ITIA says
Adds details, statements from Sinner and ATP
Aug 20 (Reuters) -World men's number one Jannik Sinner has been cleared of fault or negligence by an independent tribunal after failing two drug tests in March, the International Tennis Integrity Authority (ITIA) said on Tuesday.
The tribunal accepted Sinner's explanation that the anabolic agent clostebol entered his system from a member of his support team through massages and sports therapy, the ITIA said in a statement.
The team member had been applying an over-the-counter spray containing clostebol to their own skin to treat a small wound, the ITIA added.
"After each positive test, a provisional suspension was applied. On both occasions, Sinner successfully appealed the provisional suspension and so has been able to continue playing," the statement said.
The decision is subject to appeal by the World Anti-Doping Agency (WADA) and the Italian Anti-Doping Agency (NADO Italia), the statement added.
Sinner, who won the Cincinnati Open on Monday, said the independent tribunal had cleared him in April after he fully cooperated in the ITIA's investigation.
"I will now put this challenging and deeply unfortunate period behind me," he said in a statement, adding that the amount of clostebol found in his system was less than a billionth of a gram.
"I will continue to do everything I can to ensure I continue to comply with the ITIA's anti-doping programme and I have a team around me that are meticulous in their own compliance," he added.
The ATP said they were encouraged by the ruling.
"This has been a challenging matter for Jannik and his team, and underscores the need for players and their entourages to take utmost care in the use of products or treatments. Integrity is paramount in our sport," they said in a statement.
Australian Open champion Sinner will play in the U.S. Open later this month, with the main draw starting on Aug. 26.
Reporting by Chiranjit Ojha in Bengaluru; Editing by Hugh Lawson
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.